News

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...
Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...